NCT06726954 Repetitive Transcranial Magnetic Stimulation Therapy in Spinal Cord Injury Related Neuropathic Pain
| NCT ID | NCT06726954 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Afyonkarahisar Health Sciences University |
| Condition | Spinal Cord Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 63 participants |
| Start Date | 2024-12-16 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 63 participants in total. It began in 2024-12-16 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of our study is to investigate the effect of different protocols of high-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) therapy added to the rehabilitation program on neuropathic pain,depression, quality of life and quality of sleep compared to each other and placebo group in participants with spinal cord injury.
Eligibility Criteria
Inclusion Criteria: Aged 18-75 years Physician-diagnosed spinal cord injury for at least 3-months Neuropathic pain for at least 3-months Pain not attributable to any other conditions Exclusion Criteria: * Having an important comorbid disease such as severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, uncontrolled hypertension,arrhythmia, pacemaker) * Neurodegenerative disease * Epilepsy * History of antiepileptic drug use * Cognitive dysfunction * Lower extremity peripheral nerve injury * Increased intracranial pressure or uncontrolled migraine * Infection on the skin in the application area. * Having a brain lesion or a history of drug use that will affect the seizure threshold. Any TMS-related contraindications, for example: * Pacemaker * Metallic implant * Previous seizure * Psychiatric disorders (excluding depression and anxiety) * Malignancy * Current pregnancy
Contact & Investigator
Nuran Eyvaz, MD
PRINCIPAL INVESTIGATOR
Afyonkarahisar Health Sciences University
Frequently Asked Questions
Who can join the NCT06726954 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06726954 currently recruiting?
Yes, NCT06726954 is actively recruiting participants. Contact the research team at aysebuber007@gmail.com for enrollment information.
Where is the NCT06726954 trial being conducted?
This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).
Who is sponsoring the NCT06726954 clinical trial?
NCT06726954 is sponsored by Afyonkarahisar Health Sciences University. The principal investigator is Nuran Eyvaz, MD at Afyonkarahisar Health Sciences University. The trial plans to enroll 63 participants.